Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 09, 2025 04:00 ET | Source: MitoRx Therapeutics

MitoRx Therapeutics Expands Leadership Team with Strategic Appointments of Chief Business Officer and Finance Director

OXFORD, United Kingdom, Jan. 09, 2025 (GLOBE NEWSWIRE) -- MitoRx Therapeutics (MitoRx), a platform biotechnology company developing novel mitochondrial-targeted sulfide-donor therapeutics (mtH2SD)...
October 10, 2024 03:00 ET | Source: MitoRx Therapeutics

MitoRx Therapeutics Announces Publication Showing Mitochondrial Sulfide Donor AP39 Significantly Alleviates Obesity

OXFORD, United Kingdom, Oct. 10, 2024 (GLOBE NEWSWIRE) -- MitoRx Therapeutics (MitoRx), a platform biotechnology company developing novel mitochondrial-targeted sulfide-donor therapeutics (mtH2SD)...
October 03, 2024 03:00 ET | Source: MitoRx Therapeutics

MitoRx Therapeutics Strengthens Leadership with Key Appointments as it Reveals Obesity Programme

OXFORD, United Kingdom, Oct. 03, 2024 (GLOBE NEWSWIRE) -- MitoRx Therapeutics (MitoRx), a platform biotechnology company developing novel mitochondrial-targeted therapeutics in obesity-related...
March 07, 2024 04:00 ET | Source: MitoRx Therapeutics

MitoRx Therapeutics Strengthens Scientific Advisory Board with Appointment of Four International Experts

OXFORD, United Kingdom, March 07, 2024 (GLOBE NEWSWIRE) -- MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the...
December 13, 2023 03:00 ET | Source: MitoRx Therapeutics

MitoRx Therapeutics Announces Close of Seed Extension Financing Round to Advance its Mitochondrial-Protective Therapeutics to Treat Degenerative Diseases

OXFORD, United Kingdom, Dec. 13, 2023 (GLOBE NEWSWIRE) -- MitoRx Therapeutics (MitoRx), a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction to arrest the...
March 07, 2023 03:00 ET | Source: MitoRx Therapeutics

MitoRx Therapeutics Announces Scientific Advisory Board, Chief Development Officer and Finance Director

OXFORD, England, March 07, 2023 (GLOBE NEWSWIRE) -- MitoRx Therapeutics (MitoRx), a biotechnology company developing revolutionary therapeutics that reverse mitochondrial dysfunction to arrest the...